Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02589964 · ClinicalTrials.gov registry record · Phase 1
Probiotics in the Reduction of Antibiotic Associated Diarrhea
A Phase 1 study, sponsored by TriHealth.
- Terminated
- Registry status
- Phase 1
- Development phase
- 1
- Enrollment target
NCT02589964: Clinical Trial Phase 1 study, sponsored by TriHealth.
NCT02589964 is a Phase 1 study that was terminated before completion, run by TriHealth. The registered enrollment target is 1 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02589964, a Phase 1 study, was terminated before completion, sponsored by TriHealth.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 1 participants
- Enrollment target
Study Summary
The study will evaluate the effectiveness of probiotic therapy in reducing the incidence of antibiotic associated diarrhea (AAD) and Clostridium difficile associated diarrhea (CDAD) in pneumonia patients.
Primary Outcome
Subjects will be asked to keep a diary for 20 days after starting study treatment and will be contacted by a nurse approximately 21 days after starting study treatment
Interventions
- OTHER Placebo
- DIETARY_SUPPLEMENT Florajen-3
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2015-03 |
| Est. Completion | 2015-07 |
| Phase | Phase 1 |
Why NCT02589964 stopped before completion
NCT02589964 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 1 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT02589964 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02589964 about?
NCT02589964 is a clinical study titled "Probiotics in the Reduction of Antibiotic Associated Diarrhea". The study will evaluate the effectiveness of probiotic therapy in reducing the incidence of antibiotic associated diarrhea (AAD) and Clostridium difficile associated diarrhea (CDAD) in pneumonia patients.
What is the current status of trial NCT02589964?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 1 participants. The study started on 2015-03. Estimated completion is 2015-07.
What interventions are being tested in trial NCT02589964?
The interventions under investigation include: Placebo (OTHER), Florajen-3 (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02589964?
This trial is sponsored by TriHealth, which has 81 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02589964's enrollment target sits among peer trials
1 2001st of 2000 the lowest of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia